Related Experiment Video
Updated: Jun 9, 2026
06:39
Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
[Myelodysplastic syndrome with erythroblastopenia]
C Martinaud1, S Pons, G Ménard
1Fédération des laboratoires, HIA Sainte-Anne, 2 boulevard Sainte-Anne, Toulon cedex 9, France. christophe.martinaud@inserm.fr
La Revue De Medecine Interne
|August 31, 2010
Summary
Myelodysplastic syndrome with erythroid hypoplasia is a rare condition often misdiagnosed as pure red cell aplasia. This rare disease predominantly affects elderly males and has a poor prognosis due to transformation risks.
Area of Science:
- Hematology
- Oncology
- Stem Cell Biology
Context:
- Myelodysplastic syndromes (MDS) encompass a group of clonal hematopoietic stem cell disorders.
- Erythroid hypoplasia within MDS is poorly defined and frequently misdiagnosed.
- Distinguishing MDS with erythroid hypoplasia from acquired pure red cell aplasia is clinically significant.
Purpose:
- To clarify the definition and characteristics of myelodysplastic syndrome with erythroid hypoplasia.
- To review the literature and report on a case of this rare condition.
- To explore potential underlying mechanisms of erythroid aplasia in MDS.
Summary:
- Myelodysplastic syndrome with erythroid hypoplasia/erythroblastopenia is a rare entity, with only 50 reported cases in the last two decades.
- Affected patients are typically elderly males requiring frequent red blood cell transfusions.
- The primary concern is a poor prognosis, largely due to the risk of acute transformation.
Impact:
- Highlights the diagnostic challenges and rarity of MDS with erythroid hypoplasia.
- Underscores the poor prognosis and high transformation risk in these patients.
- Suggests a potential link between intrinsic stem cell defects and immunological factors in the pathogenesis.
Related Concept Videos
01:27Disorders of Erythrocytes
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
01:14Erythropoiesis
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
01:15Differentiation of Common Myeloid Progenitor Cells
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...